Ibicuruzwa

Acetoxy Empagliflozin, izwi kandi nka empagliflozin acetate, ni uburyo bwahinduwe bwibiyobyabwenge bya antidiabete empagliflozin.Empagliflozin ni iy'ibiyobyabwenge bizwi ku izina rya sodium-glucose co-transport 2 (SGLT2) inhibitor, zikoreshwa cyane cyane mu gucunga indwara ya diyabete yo mu bwoko bwa 2.Empagliflozin ikora ibuza SGLT2, poroteyine ishinzwe gusubiza glucose mu mpyiko.Muguhagarika iyi poroteyine, empagliflozin itera gusohora glucose binyuze mu nkari, bigatuma glucose igabanuka mu maraso ku bantu barwaye diyabete.Acetoxy Empagliflozin ni inkomoko ya empagliflozin yahinduwe hiyongereyeho itsinda rya acetoxy.Iri hinduka rigamije kuzamura umutekano no bioavailable yibiyobyabwenge, birashoboka ko byavamo umusaruro ushimishije wo kuvura.Ikoreshwa ryambere rya Acetoxy Empagliflozin rikomeje kwibanda ku micungire ya diyabete yo mu bwoko bwa 2.Iyo ifashwe mu kanwa, ikora mukugabanya impyiko glucose reabsorption, bigatuma glucose yinkari zisohoka.Ubu buryo bufasha kugabanya urugero rwa glucose yamaraso no kunoza igenzura rya glycemic kubarwayi barwaye diyabete yo mu bwoko bwa 2. Usibye ingaruka zayo zo kugabanya glucose, inhibitor za SGLT2 nka Acetoxy Empagliflozin byagaragaye ko bifite inyungu za kabiri.Ibi birimo ibishobora kunozwa mubisubizo byumutima nimiyoboro y'amaraso, nko kugabanya ibyago byo gupfa k'umutima n'imitsi, kunanirwa k'umutima, na stroke.Bashobora kandi gutuma umuntu agabanuka, kugabanya umuvuduko wamaraso, no kugabanya ibikenerwa bya insuline cyangwa indi miti igabanya ubukana.Ni ngombwa kumenya ko Acetoxy Empagliflozin, kimwe nizindi nzitizi za SGLT2, zidasabwa kubantu barwaye diyabete yo mu bwoko bwa 1 cyangwa abafite diyabete. ketoacidose.Mubisanzwe byateganijwe hamwe no guhindura imibereho, harimo indyo na siporo, kugirango hongerwe imiyoborere ya diyabete. Nkuko imiti iyo ari yo yose, Acetoxy Empagliflozin ishobora kugira ingaruka mbi, harimo kwandura inkari, kwandura mycotic (umusemburo), kwiyongera kwinkari, kuzunguruka, na hypoglycemia .Ni ngombwa ko abantu bafata iyi miti kugira ngo bakurikiranire hafi urugero rw’amaraso ya glucose kandi batange raporo ku bijyanye n'ingaruka mbi ku bashinzwe ubuzima bwabo. Muri make, Acetoxy Empagliflozin ni uburyo bwahinduwe bw’imiti igabanya ubukana bwa empagliflozin.Ikora nka SGLT2 inhibitor, ifasha kugabanya urugero rwa glucose yamaraso kubarwayi barwaye diyabete yo mu bwoko bwa 2 mu kongera glucose yinkari.Irashobora kandi gutanga inyungu zinyongera, nkibishobora kuba umutima-mitsi hamwe nibyiza bijyanye nuburemere.Nyamara, kimwe n’imiti iyo ari yo yose, ni ngombwa gukurikiza ubuyobozi bw’inzobere mu buzima kandi ugakurikiranira hafi ingaruka zose zishobora gutera.